Search In this Thesis
   Search In this Thesis  
العنوان
Safety and clinical efficacy of retropubic tension-free vaginal tape versus anti-incontinence pessary for treating women with stress urinary incontinece:
المؤلف
Etaby, Khaled Ashraf Nagiub.
هيئة الاعداد
مشرف / هشام عبد الفتاح سالم
مشرف / كوينا شاو
مشرف / فادى شوقى معيطى
مناقش / محمد عادل الناظر
الموضوع
Obstetrics. Gynecology.
تاريخ النشر
2022.
عدد الصفحات
54 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
أمراض النساء والتوليد
تاريخ الإجازة
1/8/2022
مكان الإجازة
جامعة الاسكندريه - كلية الطب - Department of Obstetrics and Gynecology
الفهرس
Only 14 pages are availabe for public view

from 79

from 79

Abstract

SUI is a major health problem affecting 20-40% of women. It is not easy to determine the exact figure of the economic burden of incontinence, however it is estimated to be $20 billion per year.
Urinary incontinence (UI) can be a burden on patient quality of life (QOL) especially with privacy and sexuality result in embarrassment and failure of doctor consultation and disclosure of the problem. Discomfort caused by feeling “wet”, “dirty” or “smelly” leads many persons to restrict their social and physical activities such as exercise, shopping, dancing, going to church and visiting friends.
Historically, pessary used was reserved for cases who are not candidate for surgery or those who decline surgery. Pessary fitting is a talent learned by experience and successful fitting is the guarantee for high continuation rate that can reach up to 90%.
FDA conducted a systematic review of literature and thus found the safety and efficacy of TVT was well established between 2009 to 2011 then shortly stopped the mandatory registering of TVT sling use to monitor complication rate, however, they issued a guideline to the use of TVT.
TVT complications in the order of frequency are pain, mesh erosion through the vagina (also called exposure, extrusion, or protrusion) being most common. Although the FDA is still approving the Tension-Free Vaginal Tape for management of stress urinary incontinence, hundreds of women joined a lawsuits against Johnson and Johnson over pelvic floor product, the FDA has banned the use of permanent mesh in the vaginal repair of pelvic organ prolapse, urogynecologist especially juniors who were not trained to perform other procedure for SUI as rectus fascia sling or retropubic urethropexy are concerned regarding the possibility of FDA banning mesh use for SUI which will leave them without surgical options for treatment of SUI, this will result in the need to extend training to be able to perform alternative surgeries than mesh- based surgery. The mesh lawsuits and the hot media topic regarding mesh based vaginal surgery was the main derive to propose this research.